Physician profile
Benjamin Scherer
NPI 1053669226
$4,087.76
in general payments reported to CMS, 2019-2025
35 companies · $321 in 2025
The $321 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,248 · 2020: $373 · 2021: $404 · 2022: $613 · 2023: $781 · 2024: $349 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,450.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $499.92 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $452.23 | 2022-2025 | Nuzyra |
| Smith+Nephew, INC. | $426.84 | 2019-2025 | Collagenase Santyl, Stravix, Grafix Pl |
| Integra Lifesciences Corporation | $330.45 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Melinta Therapeutics, LLC | $305.34 | 2019-2023 | Kimyrsa |
| Paragon 28, INC. | $271.47 | 2023-2024 | Portfolio, Hammertube Sterile Implant Kits |
| Orthofix Medical, INC. | $221.89 | 2023-2025 | Physio-Stim, Tl-Hex Truelok Hexapod System, Spinal-Stim |
| Inari Medical, INC. | $169.59 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biotissue Holdings INC. | $143.86 | 2021-2023 | |
| Bioventus LLC | $123.45 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $115.21 | 2020-2022 | |
| Trilliant Surgical LLC. | $103.40 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $98.59 | 2019-2022 | |
| Acell, INC. | $87.10 | 2019-2020 | |
| Wright Medical Technology, INC. | $80.44 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glenmark Therapeutics INC. | $75.00 | 2019 | |
| Tei Medical INC. | $69.44 | 2019 | |
| Stryker Corporation | $68.13 | 2021 | |
| Janssen Scientific Affairs, LLC | $56.26 | 2021-2022 | |
| Organogenesis INC. | $48.48 | 2021-2024 | Apligraf |
| Kci USA, INC. | $43.50 | 2021 | |
| Sandoz INC. | $43.47 | 2019 | |
| Novo Nordisk INC | $30.46 | 2024 | Ozempic, Rybelsus |
| Grt US Holding, INC. | $24.90 | 2021 | |
| Celularity INC. | $24.55 | 2020 | |
| Solventum Corporation | $23.91 | 2024 | Activ.A.C., Promogran Prisma |
| Abbott Laboratories | $20.89 | 2024 | Eterna |
| Mimedx Group, INC. | $20.14 | 2024 | |
| Sebela Pharmaceuticals INC. | $20.05 | 2021 | |
| Djo, LLC | $19.70 | 2023 | Donjoy, Aircast |
| Reprise Biomedical, INC. | $17.48 | 2024 | Miro3d |
| Tactile Systems Technology INC | $15.73 | 2020 | |
| Zyla Life Sciences, INC. | $13.77 | 2019 | |
| Medimetriks Pharmaceuticals, INC. | $12.32 | 2019 | |
| Terumo Bct, INC. | $9.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Scherer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.